Clinical Trial Update: A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating etavopivat for sickle cell disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Sickle Cell Disease | Phase 3 | Status: RECRUITING